A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
A Phase 2 clinical trial evaluating the safety and efficacy of Anavex Life Sciences‘ investigational therapy Anavex…
Stimulation of the vagus nerve, when paired with sound, could help people with Rett syndrome better process what they…
Children with Rett syndrome who can verbalize meaningful words are more likely to be able to walk past age…
Lack of a functional MeCP2 protein leads to Rett syndrome by altering levels of brain proteins associated with energy metabolism…
Preliminary clinical data from a Phase 2 trial testing Anavex-2-73 suggest the investigational therapy is effective and safe for…
Therapy that engages multiple senses in a playful context may help improve hand coordination in children with Rett syndrome, a…
A new study reports an increasing trend in the number of prenatal genetic tests to detect spontaneous mutations that can…